PATIENT-REPORTED OUTCOMES OF RESPONSE AND REMISSION FOLLOWING GUSELKUMAB INDUCTION TREATMENT AS MEASURED BY THE INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE: RESULTS THROUGH WEEK 12 OF THE PHASE 2 GALAXI 1 STUDY

Remo Panaccione  1     Geert R. D'Haens  2     Kathleen Weisel  3     Susana Gonzalez  3     Mary Elleen Frustaci  3     Zijiang Yang  4     Jewel Johanns     Matthew Germinaro     Bruce E. Sands     David T. Rubin     Chenglong Han     Julian PanĂ©s     Silvio Danese    
1 University of Calgary,Calgary,Canada
2 Amsterdam UMC,Amsterdam,Netherlands
3 Janssen Research & Development, LLC,Spring House,United States
4 Janssen Research & Development, LLC,Spring House,Unit

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing